Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures

被引:47
作者
Hesse, F [1 ]
Wagner, R [1 ]
机构
[1] Gesell Biotechnol Forsch mbH, Cell Culture Technol Dept, D-38124 Braunschweig, Germany
关键词
D O I
10.1016/S0167-7799(99)01420-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
During recent years, biopharmaceutical products manufactured by processes that use mammalian cell cultures have gained increasing importance. At the same time, a strong awareness of the importance of the safety and quality of such products has also emerged. This has led to improvements in cultivation and production technology, validation procedures and process organization.
引用
收藏
页码:173 / 180
页数:10
相关论文
共 50 条
[21]  
Hayflick L., 1984, ADV CELL CULT, V3, P303
[22]   STRATEGIES FOR OPTIMIZING SERUM-FREE MEDIA [J].
HEWLETT, G .
CYTOTECHNOLOGY, 1991, 5 (01) :3-14
[23]  
Hilleman M R, 1979, Adv Exp Med Biol, V118, P47
[24]   STATUS OF HUMAN DIPLOID CELL STRAIN MRC-5 AS AN APPROVED SUBSTRATE FOR PRODUCTION OF VIRAL VACCINES [J].
JACOBS, JP .
JOURNAL OF BIOLOGICAL STANDARDIZATION, 1976, 4 (02) :97-99
[25]  
Jager V, 1988, Cytotechnology, V1, P319, DOI 10.1007/BF00365077
[26]   PURIFICATION OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR FROM HUMAN PLASMA BY ANION-EXCHANGE CHROMATOGRAPHY [J].
JOSIC, D ;
SCHWINN, H ;
STADLER, M ;
STRANCAR, A .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 662 (02) :181-190
[27]   RATIONAL DESIGN OF PURIFICATION PROCESSES FOR RECOMBINANT PROTEINS [J].
LESER, EW ;
ASENJO, JA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 584 (01) :43-57
[28]  
Lubiniecki AS, 1997, DEV BIOL STAND, V91, P65
[29]  
LUBINIECKI AS, 1987, LARGE SCALE CELL CUL, P231
[30]  
Mather JP, 1998, METHOD CELL BIOL, V57, P19